Parexel

At Parexel, we're not just about jobs—we're about cultivating careers and unleashing potential. We're committed to your growth and dedicated to helping you reach new heights. 🚀 What sets us apart? 🔹 We offer customized training programs designed to enhance your skills and capabilities. 🔹 We invest in your long-term career goals, not just short-term gains. 🔹 We prioritize the patient, ensuring your contributions spark positive change in healthcare. Ready to transform your potential into reality? Join us: https://brnw.ch/21wQ62z #ParexelCareers #ClinicalResearch

We kicked off 2025 in San Francisco connecting with biotech leaders from around the world at the Parexel Biotech, EQT Life Sciences, and Goldman Sachs networking reception. The passion of this community inspires us, and the needs of our patients motivate us to continue doing everything we do With Heart™. Thanks to everyone who joined us and shared their insights as we continue our collaboration and raise the bar in 2025 to make a difference for patients! #ClinicalResearch #DrugDevelopment #Biotech #Biopharma #ParexelBiotech #JPM2025 #BiotechShowcase

In the latest in our #FastForward series, we explore what’s next for patient engagement and inclusion in clinical research with insights from two of our thought leaders: 💬 Stacy Hurt 🌻 emphasizes the critical need to build trusted relationships with advocacy groups to engage patients where they are—online communities and forums. 💬 Xoli Belgrave shares how the FDA’s allowance for patient data aggregation encourages earlier inclusion of diverse participants. Join the conversation—what do you think will be the biggest opportunities in patient engagement next year? Leave a comment! #ClinicalTrials #PatientEngagement #DiversityInResearch 

As many new biotech companies are preparing for their first clinical trial, there is a need to establish vital roles to support this milestone. But they do not necessarily want to bring on more permanent staff at this stage. Parexel FSP has flexible models, simple contracting processes, dedicated FSP recruiters with the network and insight to fully embed scientific, medical, regulatory and laboratory professional seamlessly into your team and culture. Our global reach and operational leadership provide the scale and customization that biotechs often need. Learn more 🔗: https://lnkd.in/gwVT_x87

How is AI advancing clinical trials today? Stephen Pyke recently said in Applied Clinical Trials Magazine, “It’s the beginning of a journey.”   From speeding up patient enrollment to streamlining regulatory submissions, AI’s potential is vast — but where will it make the biggest impact first?   💡 Share your thoughts by voting in our poll!  #AI #MachineLearning #ClinicalTrials 

With the period to transition trials to the Clinical Trials Information System (CTIS) in its final weeks, focus now turns to actions related to ongoing compliance with the EU Clinical Trial Regulation 536/2014 (EU-CTR). In this edition of the New Medicines, Novel Insights newsletter, Parexel regulatory experts Esther Gil and Celina González-Colaço outline three key considerations for sponsors with a trial transitioned with a slim dossier. Trials that benefited from a slim transition may have outstanding requirements, and companies should carefully prioritize the information to be submitted to the Member States (MSs). Read our recommendations now and be sure to subscribe for weekly #NovelInsights on the latest clinical trial news! #EUCTR #ClinicalTrials #EMA #RegulatoryAffairs

Chris A. Learn, Ph.D, PMP, SVP and Head of the Cell and Gene Center of Excellence, will speak today on healthcare access and equity as a panelist at Biotech Showcase in San Francisco. At Parexel we're committed to putting patients first and making clinical trials accessible to all. That's why we do everything #WithHeart. Connect with Parexel Biotech at Biotech Showcase: https://lnkd.in/g35p3A-7 #ClinicalResearch #DrugDevelopment #Biotech #Biopharma #ParexelBiotech #BiotechShowcase 

Meet Laura Hiijame, Manager of Project Planning and Support, whose decade-long tenure at Parexel is a testament to her dedication and unwavering support from colleagues and leadership. ➡️ https://insde.co/26td "Parexel is people," Laura emphasizes. "Our strength lies in team partnerships and cross-functional collaboration." Laura's unique background and interests shape her approach to leadership: 🚑 Before Parexel, she served 7 years in the military and worked as a paramedic 🌟 She credits her success to adaptability and empathy 🏕️ Outside work, she recharges by camping and cycling. Laura's story showcases the diverse talents and experiences that make Parexel an exceptional place to build a career in clinical research. #LifeAtParexel #ClinicalResearchCareers

Our CEO, Peyton Howell, welcomed the biotech community to the joint Parexel Biotech, EQT Life Sciences, and Goldman Sachs networking reception in San Francisco. We’re thrilled to start the year with the innovators and investors who are advancing new therapies for patients. Connect with Parexel Biotech at Biotech Showcase: https://lnkd.in/g_HQgzfX #ClinicalResearch #DrugDevelopment #Biotech #Biopharma #ParexelBiotech #JPM2025 #BiotechShowcase

Are we running out of clinical trial sites? 🏥🚨 Parexel's Karen McIntyre MSc Clinical Trials highlights a worrying industry trend: there may soon be more trials than sites to run them. But what's causing this imbalance and how can we address it? Listen to hear Karen's perspective on this critical challenge in site strategy and how we can address it. 🎙️ Stay tuned for more from our #FastForward series, where we're diving into expert predictions on drug development challenges and innovations for the coming year. #ResearchSites #ClinicalResearch #PatientsFirst